ChemoCentryx Inc

Market cap: $

Exchange: NAS

Sector: Health Technology

Share
Tweet

ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.

Key Statistics

Company Name

ChemoCentryx Inc

Average Volume (10 days)

0

Average Volume (30 days)

0

Moving Average (50 days)

$0

Moving Average (200 days)

$0

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

0

Shares Outstanding

71,355,872

52-Week High Split Adjust Only

0

52-Week Low Split Adjust Only

0

Employee Count

133

Beta

0

Next Earnings Date

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

0%

Past 30 days

0%

Past 3 months

0%

Past 6 months

0%

Past year

0%

Past 2 years

0%

Past 5 years

0%

Max % Change

0%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
ChemoCentryx IncCCXIn/an/a-6.4n/an/a
Peer AvgN/A3.676.676.73.674.42
Johnson & JohnsonJNJ5.296.77n/a5.295.40
Merck & Co IncMRK4.007.1311.74.004.51
Abbvie IncABBV3.9814.58n/a3.985.49
Pfizer Inc.PFE4.883.1610.24.885.46
AMGEN Inc.AMGN5.4314.6514.65.436.31
Bristol-Myers Squibb Co.BMY3.433.908.83.434.21
Glaxosmithkline plc - ADRGSK2.104.91n/a2.102.71
Biogen IncBIIB3.193.7714.63.193.57
Teva- Pharmaceutical Industries Ltd. - ADRTEVA0.701.14n/a0.702.12